文献速递胃肠外科

林奇综合征患者节段性或扩大切除术后异时性结直肠癌风险

Risk of Metachronous Colorectal Cancer after Segmental or Extended Resection in Patients with Lynch Syndrome.
PubMed 文献 · J Am Coll Surg · 2026-07-16

该研究基于前瞻性机构数据库,分析1969至2024年间450例林奇综合征合并结直肠癌患者。结果显示异时性结直肠癌总体发生率为20%,节段性切除组为24%,扩大切除组为5%。高危基因变异患者中扩大切除显著降低异时性癌风险,但未延长总生存。

要点

  • 林奇综合征结直肠癌患者异时性癌总体发生率为20%。
  • 高危基因变异者扩大切除较节段切除显著降低异时性癌风险。
  • 扩大切除未改善10年总生存,节段切除加密切内镜监测可作合理选择。

核心结论

  • 对于高危林奇综合征基因变异结直肠癌患者,扩大切除可显著降低异时性结直肠癌风险但不延长总生存。
  • 节段性切除联合密切内镜监测可作为合理替代方案。

研究设计与样本

  • 前瞻性机构数据库查询1969至2024年诊断为结直肠癌的林奇综合征患者,分析异时性结直肠癌发生率和10年总生存。

主要发现

  • 450例患者中88例(20%)发生异时性结直肠癌,诊断间期中位13年(四分位距5至20年)。
  • 节段性切除组350例中83例(24%)发生异时性癌,扩大切除组40例中2例(5%),未手术组60例中3例(5%)。
  • 高危基因(MLH1、MSH2)变异者异时性癌80/326例(25%),低危基因(MSH6、PMS2)变异者8/124例(6%)(p < 0.001)。
  • 高危变异者中扩大切除较节段切除异时性癌发生率更低(2/34[6%] vs 75/252[30%];p = 0.006),低危变异者中无差异(0/6 vs 8/98[8%];p = 1.00)。
  • 全队列10年总生存90%(95% CI 86%至93%),节段切除后89%(95% CI 85%至93%),扩大切除后96%(95% CI 88%至100%)。

临床怎么用

  • 高危林奇综合征基因变异结直肠癌患者可考虑扩大切除以降低异时性癌风险。
  • 低危变异患者可选择节段性切除并密切内镜监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The recommendation for patients with Lynch syndrome (LS) to undergo extended colectomy at colorectal cancer (CRC) diagnosis is increasingly controversial due to associated long-term morbidity, no benefit in overall survival, and recent advances in immunotherapy. STUDY DESIGN: A prospective institutional database was queried for patients with LS diagnosed with CRC between 1969 and 2024, and rates of metachronous CRC and 10-year overall survival were analyzed. RESULTS: Metachronous CRC, with a median of 13 (interquartile range 5 to 20) years between diagnoses, occurred in 88 of 450 patients (20%): 83 of 350 patients (24%) who underwent segmental resection, 2 of 40 patients (5%) who underwent extended resection, and 3 of 60 patients (5%) who did not undergo surgery. Metachronous CRC was more common in patients with variants in high-risk ( MLH1 , MSH2 ) vs low-risk ( MSH6 , PMS2 ) genes: 80 of 326 patients (25%) vs 8 of 124 patients (6%) (p < 0.001). Extended resection was associated with a lower rate of metachronous CRC compared with segmental resection in patients with high-risk variants (2 [6%] of 34 vs 75 [30%] of 252; p = 0.006) but not in patients with low-risk variants (0 of 6 vs 8 [8%] of 98; p = 1.00). Ten-year overall survival was 90% (95% CI 86% to 93%) for the full cohort (median follow-up, 7.0 years), 89% (95% CI 85% to 93%) after segmental resection, and 96% (95% CI 88% to 100%) after extended resection. CONCLUSIONS: For CRC patients with variants in high-risk LS genes, extended resection can significantly reduce the risk of metachronous CRC but does not lengthen overall survival. Segmental resection with close endoscopic surveillance can be a reasonable alternative, given the opportunity for repeat surgery or immune checkpoint blockade.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Hill MB, Tawantanakorn T, Gonen M, et al. Risk of Metachronous Colorectal Cancer after Segmental or Extended Resection in Patients with Lynch Syndrome. J Am Coll Surg. 2026. PMID: 41773741. doi:10.1097/XCS.0000000000001892

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。